Treatment guidelines

Evidence-based guidelines for individualizing hypertension treatment

Lifestyle Changes

Implement lifestyle modifications including improved diet, sodium reduction, increased physical activity, weight loss, and limited alcohol intake in all patients.1

Pharmacotherapy

If blood pressure remains uncontrolled after 3-6 months of lifestyle changes, promptly initiate antihypertensive drug therapy.2

For most patients without specific indications or comorbidities, first-line medication treatment should consist of:3

  • An angiotensin converting enzyme (ACE) inhibitor OR
  • An angiotensin receptor blocker (ARB)

When selecting the specific ACE inhibitor or ARB, carefully consider:

  • Supporting data on efficacy, safety, side effects in relevant patient demographics and conditions1
  • Favorable tolerability profile promoting long-term adherence1
  • Duration of action providing consistent 24-hour blood pressure lowering

Additionally, preferred agents should have:

  • Proven efficacy in resistant hypertension as add-on therapy1
  • Demonstrated additional systolic and diastolic BP lowering when used as add-on therapy in patients uncontrolled on 3 antihypertensives1
  • Duration of action providing consistent 24-hour blood pressure lowering
  • Proven ability to provide consistent 24-hour BP control rather than short-acting intermittent effects1

Titration and Monitoring

Uptitrate the selected agent to maximum tolerated dose before adding complementary agents from other classes if needed to achieve goals.3,4

Closely monitor the treatment response and adjust therapy until targets are reached:

  • Switch agents if side effects, non-adherence issues, or lack of 24hr BP control arise
  • Add agents from complementary classes (CCBs, thiazide diuretics, etc.) for enhanced efficacy per guidelines
  • Continually modify regimen based on evolving patient needs and risks

The optimal treatment approach starts with an evidence-based selection of the most appropriate ACE inhibitor or ARB, followed by diligent patient-centric titration and adjustments to meet treatment targets.

References:
1 - ESC/ESH. (2021). Guideline for the management of arterial hypertension. [ESC/ESH Guidelines]. https://academic.oup.com/eurheartj/article/42/36/3227/6358045
2 - ASH/ACC/AHA. (2022). Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults. [Hypertension Guideline]. https://www.ahajournals.org/doi/10.1161/HYP.0000000000001733
3 - BNF. (2022). Treatment of hypertension. [BNF 88]. https://bnf.nice.org.uk/treatment-summary/hypertension.html
4 - JNC-8. (2014). 2014 evidence-based guideline for the management of high blood pressure in adults. [JNC-8 Guidelines]. https://jamanetwork.com/journals/jama/fullarticle/1791497

Individualizing treatment: A case-based approach

Learn approaches to properly tailor hypertension management through interactive case studies with Dr. Park in this on-demand webinar.